Cat.No. : CSC-SC012928 Host Cell: HEK293 (CHO and other cell types are also available)
| Cat. No. | CSC-SC012928 |
| Description | Using Creative Biogene's proprietary lentiviral vectors, we subclone the target gene into lentivector, generate the lentivirus particles, sequentially infect the cell line HEK293 (other cell types are also available according to your requirements), and select the clones constantly expressing target gene at high level. |
| Gene | RAF1 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293 (CHO and other cell types are also available) |
| Stability | Validated for at least 10 passages |
| Application | 1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Size Form | 2 × 10^6 cells / vial |
| Shipping | Dry Ice |
| Storage | Liquid nitrogen |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Gene Name | RAF1 v-raf-1 murine leukemia viral oncogene homolog 1 [ Homo sapiens ] |
| Gene Symbol | RAF1 |
| Synonyms | RAF1; v-raf-1 murine leukemia viral oncogene homolog 1; RAF proto-oncogene serine/threonine-protein kinase; c Raf; CRAF; Raf 1; Oncogene RAF1; proto-oncogene c-RAF; raf proto-oncogene serine/threonine protein kinase; NS5; Raf-1; c-Raf; |
| Gene ID | 5894 |
| UniProt ID | P04049 |
| mRNA Refseq | BC018119 |
| Chromosome Location | 3p25 |
| Function | ATP binding; MAP kinase kinase kinase activity; Ras GTPase binding; metal ion binding; mitogen-activated protein kinase kinase binding; nucleotide binding; protein binding; protein heterodimerization activity; protein kinase acti |
| Pathway | ARMS-mediated activation, organism-specific biosystem; Activation of NMDA receptor upon glutamate binding and postsynaptic events, organism-specific biosystem; Acute myeloid leukemia, organism-specific biosystem; Acute myeloid leukemia, conserved biosystem; Adaptive Immune System, organism-specific biosystem; Androgen Receptor Signaling Pathway, organism-specific biosystem; Axon guidance, organism-specific biosystem; |
| MIM | 164760 |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
Raf-1 proto-oncogene, serine/threonine kinase (Raf1), is a crucial component of the RAS/RAF/MEK/ERK signaling pathway, regulating cell migration, apoptosis, and differentiation. However, research on Raf1 expression and its clinical significance in non-small cell lung cancer (NSCLC) is limited. Here, researchers explored the clinical value and prognostic significance of Raf1 in NSCLC patients after radiotherapy. The study found that Raf1 expression was significantly associated with the invasive and metastatic abilities of lung cancer A549 and H1299 cell lines. Results showed that Raf1 expression was present in 44.5% of NSCLC patient specimens, and Raf1 expression was positively correlated with lymph node metastasis, T stage, and histological poor differentiation. Patients with negative or low Raf1 expression experienced slower disease progression than those with high Raf1 expression. Multivariate analysis indicated that Raf1 was an independent prognostic factor for time to progression (TTP). High Raf1 expression was associated with poorer 3-year overall survival (OS). Raf1 overexpression was associated with early progression of NSCLC. Raf1 may become a novel prognostic factor and potential target for improving the long-term prognosis of NSCLC patients.
Here, researchers performed in vitro gain-of-function analyses to investigate the effects of Raf1 on lung cancer cell invasion and migration. Scratch healing assays showed that Raf1-overexpressing A549 cells exhibited enhanced lateral migration, while Raf1-silenced H1299 cells showed diminished lateral migration (Figure 1). Transwell invasion assays also demonstrated that Raf1-overexpressing A549 cells exhibited enhanced invasiveness, while Raf1-silenced H1299 cells showed diminished invasiveness (Figure 2). In summary, these results indicate that Raf1 can promote the migration and invasion of lung cancer cells.
Figure 1. Wound healing assay showed that Raf1 expression affects the lateral migration in lung cancer cells. (Tian H, et al., 2018)
Figure 2. Transwell invasion assay shows that the Raf1 expression affects the invasion ability in lung cancer cells. (Tian H, et al., 2018)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.
Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Copyright © Creative Biogene. All rights reserved.
